Cell-Surface Marking of CD34+-Restricted Phenotypes of Human Hematopoietic Progenitor Cells by Retrovirus-Mediated Gene Transfer
- 1 September 1997
- journal article
- research article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 8 (13) , 1611-1623
- https://doi.org/10.1089/hum.1997.8.13-1611
Abstract
Human CD34+ cells lacking detectable levels of HLA-DR antigens (CD34+ DR¯) are highly enriched in hematopoietic pluripotent progenitors with long-term marrow repopulating ability. We investigated the feasibility of transducing and marking CD34+ DR¯ progenitor cells from bone marrow (BM) or mobilized peripheral blood samples (MPB) of 13 patients undergoing BM transplantation with the purpose of developing a protocol for a large-scale clinical application. A new retroviral vector coding for the truncated form (Δ) of the low-affinity nerve growth factor receptor (LNGFR) was used to quantitate the level of gene transfer into CD34+ cells and their progeny by multiparameter cytofluorimetry and immunocytochemistry. Light-density mononuclear cells as well as purified CD34+ cells were transduced either by direct incubation with retroviral supernatants or prestimulated in vitro with various combinations of growth factors prior to transduction. Transduction efficiency, assessed as G418-resistant growth of granulocyte-macrophage colony-forming units (CFU-GM) progenitors from MPB, was 1.7-fold higher (14.9% ± 4.5%) than those from BM (8.5% ± 3.9%) and it was further improved (26.9% ± 3.1%) using a purified CD34+ population as target cells. Three-color fluorescence-activated cell sorting (FACS) analysis demonstrated the presence of transduced ΔLNGFR+ cells within the CD34+ DR¯ subpopulation. In the absence of growth factors, gene transfer into BM or MPB CD34+ DR¯ cells was generally poor, but following a 72-hr prestimulation it peaked at 38% of total CD34+ DR¯ bone marrow (BM) cells in the presence of the c-kit ligand (KL) and at 31% in the presence of IL-3. Furthermore, KL gave, compared to the other cytokines, the highest absolute yield of BM ΔLNGFR+ CD34+ DR¯ cells recovered after transduction (p = 0.05 compared to 24 hr). Gene transfer into in vitro primitive progenitor cells was further confirmed by expression of the ΔLNGFR marker on CD34+ cells and CFU-GM derived from 5-week long-term culture on stroma. We have developed a new retroviral vector encoding a truncated form of the low-affinity nerve growth factor receptor (ΔLNGFR) suitable for a sensitive detection and isolation of transduced hematopoietic progenitor cells. The use of ΔLNGFR cell-surface marker allowed us to study at single-cell level the effect of different combinations of cytokines on gene transfer of restricted phenotypes of hematopoietic progenitor cells from bone marrow and mobilized peripheral blood samples.Keywords
This publication has 32 references indexed in Scilit:
- HSV-TK Gene Transfer into Donor Lymphocytes for Control of Allogeneic Graft-Versus-LeukemiaScience, 1997
- Gene Therapy in Peripheral Blood Lymphocytes and Bone Marrow for ADA − Immunodeficient PatientsScience, 1995
- Transduction of MDR1 into human and mouse haemopoietic progenitor cells: use of rhodamine (Rhl23) to determine transduction frequency and in vivo selectionBritish Journal of Haematology, 1995
- Retrovirus‐mediated transfer of the multidrug resistance gene into human haemopoietic progenitor cellsBritish Journal of Haematology, 1994
- Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patientsThe Lancet, 1993
- Purified primitive human hematopoietic progenitor cells with long-term in vitro repopulating capacity adhere selectively to irradiated bone marrow stroma.The Journal of Experimental Medicine, 1990
- Construction and use of a safe and efficient amphotropic packaging cell lineVirology, 1988
- Characterization of a human hematopoietic progenitor cell capable of forming blast cell containing colonies in vitro.Journal of Clinical Investigation, 1988
- Expression and structure of the human NGF receptorCell, 1986
- Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).Journal of Histochemistry & Cytochemistry, 1984